Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-07

FDA Approved: CLARITIN REDITABS — Supplemental Application (Bayer Healthcare LLC.)

View source ↗

Summary

The FDA approved a supplemental application for CLARITIN REDITABS (loratadine) from Bayer Healthcare LLC., likely authorizing a new or modified dosage form with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Claritin RediTabs (Loratadine)

Snippet

SUPPL AP for CLARITIN REDITABS (LORATADINE)